Minimally Invasive Uterine Fibroid Treatment is fastest growing segment fueling growth of U.S. Uterine Fibroid Treatment Market

 

The U.S. Uterine Fibroid Treatment Market is estimated to be valued at US$ 269.4 Mn or Million in 2023 and is expected to exhibit a CAGR of 4.0% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
Uterine fibroids are non-cancerous growths that develop in or on a woman's uterus. They require treatment through non-hormonal and minimally invasive procedures to reduce heavy bleeding, pelvic pressure and pain.

Market key trends:
One of the key trends in the U.S. uterine fibroid treatment market is the rising adoption of minimally invasive treatment procedures such as uterine fibroid embolization and microwave thermotherapy. These procedures are associated with reduced treatment costs, lesser hospital stay and faster recovery time compared to hysterectomy. They utilize imaging guidance for precisely targeting and eliminating fibroids through catheter based delivery of embolic agents or heat energy. This has fueled their popularity among women aiming to preserve fertility.
Segment Analysis
The U.S. uterine fibroid treatment market is segmented based on treatment into embolization, medication, myomectomy (surgical removal of fibroids), hysterectomy (surgical removal of the uterus), and others. The embolization segment currently dominates the market owing to its minimally invasive nature and high success rate in removing uterine fibroids. Additionally, embolization has seen wider adoption compared to other treatments due to improved clinical success with fewer side effects and shorter recovery time.

Key Takeaways
The U.S. uterine fibroid treatment market is expected to witness high growth, exhibiting CAGR of 4.0% over the forecast period, due to increasing prevalence of uterine fibroids and growing awareness regarding treatment.

Regional analysis
The Western region dominates the U.S. uterine fibroid treatment market currently owing to higher preference for minimally invasive treatments and presence of key players. California represents the fastest growing regional market.

Key players
Key players operating in the U.S. uterine fibroid treatment market are Blue Endo, Boston Scientific Corporation, CooperSurgical, Inc., Karl Storz SE & Co. KG, Myovant Sciences GmbH, Halt Medical, Inc., LiNA Medical ApS, Merit Medical Systems, Olympus Corporation, and Richard Wolf GmbH.

Comments

Post a Comment

Popular posts from this blog

Unveiling Health Secrets: Exploring the Potential of Blood-Based Biomarkers

Image
  The human body is a complex and intricate system, often harboring subtle signs of its inner workings. One of the most promising avenues for unlocking these secrets lies within our bloodstream – a treasure trove of information encoded in the form of blood-based biomarkers. These biomarkers, measurable indicators present in the blood, hold the potential to revolutionize healthcare by providing early detection, accurate diagnosis, and personalized treatment approaches. Blood-based biomarkers encompass a wide range of molecules – from proteins and nucleic acids to metabolites and even circulating cells. Researchers have been diligently working to identify specific biomarkers associated with various diseases and conditions. For instance, elevated levels of certain proteins might point to cardiovascular diseases, while specific genetic material could indicate the presence of cancer. By analyzing these biomarkers, clinicians gain valuable insights into an individual's health status, en...
Read more

Revolutionizing Biology: Advancements in Single Cell Analysis Techniques

Image
  Single cell analysis has emerged as a groundbreaking technology that is revolutionizing the field of biology. Traditionally, biological studies were conducted on populations of cells, averaging out the heterogeneity present within them. However, the advent of single cell analysis has enabled scientists to delve into the complexity of individual cells, uncovering a wealth of previously inaccessible information. Advancements in single cell analysis techniques have paved the way for a deeper understanding of cellular heterogeneity, gene expression, and cellular behavior. One of the most remarkable techniques is single-cell RNA sequencing (scRNA-seq), which allows scientists to measure gene expression in individual cells. This breakthrough has led to the identification of rare cell types, understanding of cellular communication networks, and the discovery of novel biomarkers. Moreover, single cell imaging techniques, such as single cell fluorescence microscopy, have enabled research...
Read more

Medical Robots Market Poised to Grow Owing to Improving Healthcare Infrastructure

Image
 The Medical Robots Market is anticipated to witness robust growth due to rising healthcare spending across the globe. Medical robots are used to perform minimal invasive surgeries with greater accuracy and flexibility. Growing preference for Robot-Assisted Surgery (RAS) over conventional open surgeries due to benefits such as shorter recovery time and minimum operative scars has been augmenting demand for medical robots. Key functions include guiding and positioning surgical accessories like guide tubes in radiology and guiding catheter and wires in cardiology. With rising chronic disease prevalence associated with aging populations, the need for more surgical procedures is surging which requires precise action minimally invasive robotic systems can provide. The Global Medical Robots Market is estimated to be valued at US$ 11.47 Bn in 2024 and is expected to exhibit a CAGR of 16% over the forecast period 2023 to 2030. Key Takeaways: Key players operating in the Medical Robo...
Read more